Company news
BioRestorative Therapies, Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
BioRestorative Therapies Awarded an STTR Phase I Grant to Explore the Therapeutic Effects of PEG-Peptide Hydrogel-Encapsulated Hypoxic Bone Marrow Stem Cells
January 3, 2022
BioRestorative Therapies Announces CRO Agreement with PRC Clinical for its BRTX-100 Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease
December 20, 2021
BioRestorative Therapies, Inc. Releases Year-End Message
December 19, 2021
BioRestorative Therapies Announces Filing of Ten Patent Applications Related to its BRTX-100 Program
December 1, 2021
BioRestorative Therapies Enters into Letter of Intent with PRC Clinical
November 18, 2021
BioRestorative Therapies Appoints Robert Kristal as Chief Financial Officer
November 9, 2021
BioRestorative Therapies Announces Closing of $23 Million Public Offering
November 8, 2021
BioRestorative Therapies Announces Nomination of Two New Members to the Board of Directors
October 25, 2021
BioRestorative Therapies Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to Nasdaq
October 25, 2021
BioRestorative Therapies Receives Notice of Allowance for Patent Application in Israel for its Metabolic Program
September 22, 2021
BioRestorative Therapies Receives Patent in Australia Related to its Off-the-Shelf ThermoStem® Program
September 1, 2021
BioRestorative Therapies Receives Patent in Japan Related to its Off-the-Shelf ThermoStem® Program
August 30, 2021
BioRestorative Therapies Announces Filing of Registration Statement for Proposed Public Offering
August 8, 2021
BioRestorative Therapies Expanding its Cell Therapy Manufacturing Facility
May 9, 2021
BioRestorative Therapies Announces Compliance with SEC Reporting Requirements and “Stop Sign” Removal
May 2, 2021
BioRestorative Therapies Announces Appointment of Nickolay V. Kukekov, Ph.D to its Board of Directors
April 4, 2021
BioRestorative Therapies Announces Notice of Allowance for a New Patent Application Related to its Off-the-Shelf ThermoStem® Program
March 30, 2021
BioRestorative Therapies Announces Notices of Allowance for Three Patent Applications for its Off-the-Shelf ThermoStem® Program
March 21, 2021
BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K
March 17, 2021
BioRestorative Therapies Emerges from Chapter 11 Reorganization
November 19, 2020
BioRestorative Therapies Receives Patent in Israel For Its Metabolic Program
December 11, 2019
Calls
The 5 newest of 7 calls. Every call is listed under its year.
- BioRestorative Therapies (NASDAQ:BRTX) Q3 2025 Earnings Call
Nov 12, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q2 2025 Earnings Call
Aug 12, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q1 2025 Earnings Call
May 14, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q4 2024 Earnings Call
Mar 27, 2025
Transcript - BioRestorative Therapies (NASDAQ:BRTX) Q3 2024 Earnings Call
Nov 13, 2024
Transcript
Decks
The 5 newest of 44 decks. Every deck is listed under its year.
- Investor Presentation (April 2026)
Investor deck · 37 slides · Apr 23, 2026
- Investor Presentation (September 2025)
Investor deck · 27 slides · September 2025
- Investor Presentation (August 2025)
Investor deck · 27 slides · Aug 14, 2025
- Q1 2025 Earnings Presentation
Earnings · 27 slides · May 14, 2025
- Investor Presentation (May 2025)
Investor deck · 27 slides · May 2025